High Seroprevalence of Bloodborne Viruses among Street‐Recruited Injection Drug Users from Buenos Aires, Argentina
Open Access
- 15 December 2003
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 37 (s5) , S348-52
- https://doi.org/10.1086/377560
Abstract
Injection drug use is the main mechanism of human immunodeficiency virus (HIV) transmission in Argentina (40% of reported AIDS cases in Argentina). This study was conducted among street-recruited injection drug users (IDUs) from Buenos Aires, with the aim of estimating seroprevalence and coinfection of HIV, hepatitis B virus (HBV), hepatitis C virus (HCV), and human T-lymphotropic viruses (HTLVs). A total of 174 volunteers participated in this study; 137 were men (78.7% of volunteers). The average age of the participants was 30 years. Only 64 of participants (37%) had no viral infection, whereas 110 (63%) were infected with ⩾1 viruses. Seroprevalences were 44.3% for HIV, 54.6% for HCV, 42.5% for HBV, 2.3% for HTLV-I, and 14.5% for HTLV-II. Among the 77 HIV-infected persons, only 6.5% (5 persons) were not coinfected with other viruses; 88.3% (68) were coinfected with HCV and 68.8% (53) were coinfected with HBV. We demonstrated the existence of multiple viral infections with a high rate of prevalence in IDUs in Buenos Aires, Argentina.Keywords
This publication has 4 references indexed in Scilit:
- Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Prevention in Injection Drug Users and Their Partners and Children: Lessons Learned in Latin America—The Argentinean CaseClinical Infectious Diseases, 2003
- Epidemiology of Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Syndrome in Injection Drug Users in Argentina: High Seroprevalence of HIV InfectionClinical Infectious Diseases, 2003
- The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: A long-term retrospective cohort studyHepatology, 2001
- Role of Drug Injection in the Spread of HIV in Argentina and BrazilInternational Journal of STD & AIDS, 1993